The role of healthcare professionals’ communication in trial participation decisions: a qualitative investigation of recruitment consultations and patient interviews across three RCTs
2024

How Healthcare Communication Affects Trial Participation Decisions

Sample size: 62 publication 10 minutes Evidence: moderate

Author Information

Author(s): Farrar Nicola, Elliott Daisy, Jepson Marcus, Young Bridget, Donovan Jenny L., Conefrey Carmel, Realpe Alba X., Mills Nicola, Wade Julia, Lim Eric, Stein Robert C., Caskey Fergus J., Rooshenas Leila

Primary Institution: Population Health Sciences, University of Bristol

Hypothesis

How do patients interpret and use information from healthcare professionals in their decisions about participating in clinical trials?

Conclusion

Healthcare professionals significantly influence patients' perceptions of treatment options, which affects their decisions to participate in clinical trials.

Supporting Evidence

  • Patients often felt that healthcare professionals favored certain treatments, which influenced their decisions.
  • Communication about treatment options was often imbalanced, affecting patients' understanding of their choices.
  • Patients' decisions were shaped by early discussions with healthcare professionals before trial information was presented.

Takeaway

When doctors talk to patients about clinical trials, what they say can really change how patients feel about joining the trial. Patients often think about what the doctors say when deciding if they want to participate.

Methodology

The study used audio recordings of recruitment consultations and interviews with patients to analyze how information was communicated and interpreted.

Potential Biases

Potential bias in how healthcare professionals present treatment options, which may influence patient perceptions.

Limitations

Demographic details were not collected, making it difficult to assess the transferability of findings across different populations.

Participant Demographics

Patients from three different RCTs with varying conditions, including cancer and kidney disease.

Digital Object Identifier (DOI)

10.1186/s13063-024-08656-y

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication